deltatrials
Recruiting OBSERVATIONAL NCT01772771

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

Sponsor: M.D. Anderson Cancer Center

Conditions Glioma Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm Melanoma Sarcoma
Interventions Biospecimen Collection Genetic Testing Medical Chart Review
Updated 20 times since 2017 Last updated: Feb 27, 2026 Started: Mar 1, 2012 Primary completion: Mar 1, 2032 Completion: Mar 1, 2033
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01772771, this observational or N/A phase trial focuses on Glioma and Hematopoietic and Lymphoid Cell Neoplasm and remains actively recruiting participants. Sponsored by M.D. Anderson Cancer Center, it has been updated 20 times since 2012, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Sep 2017 · 31 days · monthly snapshot~Sep 2017 – ~Apr 2018 · 7 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Jun 2019 · 8 months · monthly snapshot~Jun 2019 – ~Nov 2020 · 17 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Dec 2021 · 7 months · monthly snapshot~Dec 2021 – ~Feb 2023 · 14 months · monthly snapshot~Feb 2023 – ~Sep 2023 · 7 months · monthly snapshot~Sep 2023 – ~Mar 2024 · 6 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshot~Apr 2025 – ~Sep 2025 · 5 months · monthly snapshot~Sep 2025 – ~Mar 2026 · 6 months · monthly snapshot~Mar 2026 – present · 6 months · monthly snapshot

Change History

20 versions recorded

  1. Mar 2026 — Present [monthly]

    Recruiting

  2. Sep 2025 — Mar 2026 [monthly]

    Recruiting

  3. Apr 2025 — Sep 2025 [monthly]

    Recruiting

  4. Sep 2024 — Apr 2025 [monthly]

    Recruiting

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting

▶ Show 15 earlier versions

  1. Mar 2024 — Jul 2024 [monthly]

    Recruiting

  2. Sep 2023 — Mar 2024 [monthly]

    Recruiting

  3. Feb 2023 — Sep 2023 [monthly]

    Recruiting

  4. Dec 2021 — Feb 2023 [monthly]

    Recruiting

  5. May 2021 — Dec 2021 [monthly]

    Recruiting

  6. Jan 2021 — May 2021 [monthly]

    Recruiting

  7. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  8. Jun 2019 — Nov 2020 [monthly]

    Recruiting

  9. Oct 2018 — Jun 2019 [monthly]

    Recruiting

  10. Jun 2018 — Oct 2018 [monthly]

    Recruiting

  11. May 2018 — Jun 2018 [monthly]

    Recruiting

  12. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  13. Sep 2017 — Apr 2018 [monthly]

    Recruiting NA

  14. Aug 2017 — Sep 2017 [monthly]

    Recruiting NA

  15. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
  • National Cancer Institute (NCI)
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations